A synthetic peptide that binds strongly to multiple tumor-associated integrins, enabling targeted delivery to solid tumors while minimizing exposure to healthy tissue.

A therapeutic approach that uses the PIP platform to deliver cytotoxic drugs directly to solid tumors.